Background
This is a low grade Non-Hodgkin's lymphoma (NHL), B-cell immunophenotype. Unlike most cases of diffuse small cell lymphomas, this lymphoma tends to occur with localized rather than generalized lymphadenopathy. This lymphoma is the lymph node equivalent of MALT lymphoma, lymphomas arising within mucosal-associated tissues such as the gastrointestinal tract and salivary glands. It is more accurately diagnosed as a marginal zone lymphoma.
OUTLINE
EPIDEMIOLOGY CHARACTERIZATION SYNONYMS Marginal zone lymphoma
Monocytoid B-cell lymphomaINCIDENCE Less common than other types of diffuse small cell lymphomas SEX (M:F)Females are 2-5x more likely
DISEASE ASSOCIATIONS CHARACTERIZATION Autoimmune disorders Sjogren's syndrome
CLINICAL VARIANTS CHARACTERIZATION SPLEEN EXTRA-NODAL MALT LYMPHOMAS PEDIATRIC
Marginal zone B-cell lymphoma in children and young adults.Taddesse-Heath L, Pittaluga S, Sorbara L, Bussey M, Raffeld M, Jaffe ES.
Am J Surg Pathol 2003 Apr;27(4):522-31 Abstract quote We describe the clinicopathologic findings of 48 cases of marginal zone B-cell lymphoma (MZL) in children and young adults, a disease that has been recognized previously only rarely in this age group.
Patients ranged in age from 2 to 29 years, with pediatric patients (</=18 years) comprising 52% of the cases. As in adults, both primary nodal (N) and extranodal (E) MZL were observed. However, primary NMZL comprised the majority of the cases (67%) and demonstrated distinctive clinical and histologic features. NMZL occurred most commonly in young males (median 16 years, male/female ratio 5.4:1), with no underlying disease, presenting as localized adenopathy (90% stage I), with excellent prognosis and low rate of recurrence. In contrast, EMZL were much less common, and patients were older (median 24.5 years), with only a slight male predominance (male/female ratio 1.2:1). Most patients had localized disease (73% stage I) with excellent prognosis and infrequent recurrences. In addition, an association with autoimmune disease was observed in 19% of the EMZL.
Both primary NMZL and EMZL in young patients shared similar morphologic and immunophenotypic findings to those described in adults and were monoclonal B-cell proliferations with monoclonality demonstrated in 94% of the cases. A common morphologic feature in NMZL was disruption of residual follicles resembling progressive transformation of germinal centers (PTGC), observed in 66% of the cases. Although the precise relationship of primary NMZL and the PTGC-like changes is unclear, it is possible that NMZL arises in a background of PTGC, as florid PTGC often occurs in young males.
We conclude that EMZL in children and young adults are similar to EMZL of mucosa-associated lymphoma tissue occurring in older patients. However, pediatric NMZL appear to have distinctive clinical and histologic features.
SKIN
J Cutan Pathol. 2006 Mar;33(3):236-41. Abstract quote
Marginal zone lymphoma (MZL) is an indolent neoplasm of mature B cells, classified by the World Health
Organization into three categories: nodal, splenic, and extranodal MZL of mucosa-associated lymphoid tissue (MALT lymphoma). We present an unusual case of MZL with cutaneous, leukemic, and bone marrow involvement at presentation and expression of an aberrant myeloid-monocytic phenotype.
This case is best classified as MZL of leukemic subtype.Primary Cutaneous Marginal Zone B-Cell Lymphoma Clinical and Therapeutic Features in 50 Cases
J. J. Hoefnagel, MD; M. H. Vermeer, MD, PhD; P. M. Jansen, MD, PhD; F. Heule, MD, PhD; P. C. van Voorst Vader, MD, PhD; C. J. G. Sanders, MD; M. J. P. Gerritsen, MD, PhD; M. L. Geerts, MD, PhD; C. J. L. M. Meijer, MD, PhD; E. M. Noordijk, MD, PhD; R. Willemze, MD, PhD; for the Dutch Cutaneous Lymphoma Working Group
Arch Dermatol. 2005;141:1139-1145. Abstract quote Background Primary cutaneous marginal zone B-cell lymphoma (PCMZL) is a low-grade B-cell lymphoma that originates in the skin, with no evidence of extracutaneous disease. Studies focusing on the optimal treatment of PCMZL have not been published thus far. We describe 50 patients with PCMZL to further characterize clinical characteristics and outcome and, in particular, to evaluate our current therapeutic approach.
Observations The majority of the patients (36/50 [72%]) presented with multifocal skin lesions, and 14 patients (28%) presented with solitary or localized lesions. The initial treatment of patients with solitary lesions consisted of radiotherapy or excision, whereas patients with multifocal lesions received a variety of initial treatments, most commonly radiotherapy and chlorambucil therapy. Cutaneous relapses developed in 19 (48%) of 40 patients who had complete remission and were more common in patients with multifocal disease. After a median period of follow-up of 36 months, 2 patients developed extracutaneous disease, but none of the patients died of lymphoma.
Conclusions Patients with PCMZL who have solitary lesions can be treated effectively with radiotherapy or excision. For patients with PCMZL who have multifocal lesions, chlorambucil therapy and radiotherapy are suitable therapeutic options. In case of cutaneous relapses, the beneficial effects of treatment should carefully be weighed against the potential adverse effects.
SPECIAL STAINS/
IMMUNOPEROXIDASE/
OTHERCHARACTERIZATION Positive Surface Ig (mostly IgM)
Cytoplasmic Ig in about 40%
Pan B (CD19, CD20, CD22, CD 79a)
BCL-2 proteinNegative CD5, CD10, CD23
DIFFERENTIAL DIAGNOSIS KEY DIFFERENTIATING FEATURES MANTLE CELL LYMPHOMA
- Mantle cell lymphoma disguised as marginal zone lymphoma.
Jacobson E, Burke P, Tindle BH.
Department of Pathology and Fletcher Allen Health Care, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Arch Pathol Lab Med. 2005 Jul;129(7):929-32. Abstract quote
We report a case of mantle cell lymphoma histologically indistinguishable from marginal zone lymphoma. An 83-year-old man presented with a 9.0-cm, slowly enlarging axillary mass.
Microscopically, the neoplastic process was largely interfollicular, surrounding residual follicular centers, some of which had discernible small lymphocyte mantles. Overall, the morphologic pattern was highly suggestive of marginal zone lymphoma.
However, flow cytometric and immunohistochemical results, including cyclin D1 positivity, revealed an immunophenotype that fit with mantle cell lymphoma. The differential diagnosis of mantle cell lymphoma is broad, and it is well known that mantle cell lymphoma can assume a number of histologic appearances, including, infrequently, that of more indolent B-cell non-Hodgkin lymphomas.
Although not pathognomonic, cyclin D1 positivity is highly specific for mantle cell lymphoma and is key in distinguishing these clinically dissimilar malignant lymphomas. In recent years, detection of cyclin D1 has expanded the recognizable histologic spectrum of mantle cell lymphoma.PERIPERHAL T-CELL LYMPHOMA
Peripheral T-cell lymphoma mimicking marginal zone B-cell lymphoma.Uherova P, Ross CW, Finn WG, Singleton TP, Kansal R, Schnitzer B.
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0602, USA.
Mod Pathol 2002 Apr;15(4):420-5 Abstract quote Peripheral T-cell lymphoma (PTCL) may assume a variety of histologic and cytologic appearances.
We describe eight cases of PTCL morphologically simulating marginal zone B-cell lymphoma. We reviewed PTCL cases diagnosed in our institution between 1990 and 2000 and selected eight cases for study based on the following criteria: small-cell morphology with abundant, clear cytoplasm and either marginal zone involvement by the neoplastic infiltrate in lymph node biopsies or lymphoepithelial lesions in extranodal biopsies. Histologic features and ancillary studies were reviewed. Patients included six women and two men with a median age of 53 years (range, 35 to 74 years). Six patients were diagnosed with primary nodal PTCL, and two presented with primary extranodal disease. The original diagnosis was PTCL in only four cases; three cases were diagnosed as atypical lymphoid infiltrate, and one case as benign lymphoepithelial lesion.
Lymph node biopsies revealed partial effacement of the architecture with residual follicles surrounded by the neoplastic small cells. Extranodal sites included hard palate, tongue, tonsil, and submandibular glands; all but one case demonstrated lymphoepithelial lesions. Monoclonality was demonstrated in six of eight cases (rearrangement of T-cell receptor gene), and three of eight had an aberrant T-cell population by flow cytometry. The differential diagnosis of atypical lymphoid infiltrates with morphologic features of marginal zone B-cell lymphoma should include PTCL.
This uncommon morphological mimicry should be recognized, because PTCL is an aggressive disease regardless of morphology and should be treated accordingly.
PROGNOSIS AND TREATMENT CHARACTERIZATION Prognostic Factors Transformation to a large cell lymphoma is a poor prognostic feature Henry JB. Clinical Diagnosis and Management by Laboratory Methods. Twentieth Edition. WB Saunders. 2001.
Rosai J. Ackerman's Surgical Pathology. Ninth Edition. Mosby 2004.
Sternberg S. Diagnostic Surgical Pathology. Fourth Edition. Lipincott Williams and Wilkins 2004.
Robbins Pathologic Basis of Disease. Seventh Edition. WB Saunders 2005.
DeMay RM. The Art and Science of Cytopathology. Volume 1 and 2. ASCP Press. 1996.
Weedon D. Weedon's Skin Pathology Second Edition. Churchill Livingstone. 2002
Fitzpatrick's Dermatology in General Medicine. 6th Edition. McGraw-Hill. 2003.
Weiss SW and Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. Fourth Edition. Mosby 2001.
Splenic Marginal Zone Lymphoma
Basic Principles of Disease
Learn the basic disease classifications of cancers, infections, and inflammation
Commonly Used Terms
This is a glossary of terms often found in a pathology report.Diagnostic Process
Learn how a pathologist makes a diagnosis using a microscopeSurgical Pathology Report
Examine an actual biopsy report to understand what each section meansSpecial Stains
Understand the tools the pathologist utilizes to aid in the diagnosisHow Accurate is My Report?
Pathologists actively oversee every area of the laboratory to ensure your report is accurateGot Path?
Recent teaching cases and lectures presented in conferences
Last Updated April 10, 2006
Send mail to The Doctor's Doctor with questions or comments about this web site.
Read the Medical Disclaimer.
Copyright © The Doctor's Doctor